Skip to content
close icon

Pediatric Patients with Insomnia Disorder

NO LONGER ACCEPTING APPLICATIONS
Published on:
March 10, 2025
Sign-up Expiration:
Updated:
Topics:
Sleep Disorder
Insomnia
Dr. Robert Nahouraii
Children's Health
Locations:
Charlotte, NC
Dr. Robert Nahouraii

Insomnia is defined by difficulties in initiating or maintaining sleep, or early-morning awakening with an inability to return to sleep and it is associated iwth experiencing nonrestorative sleep. Insomnia places a significant toll on individuals (impairs the individual's functioning, has a negative impact on the individual's quality of life, and increases risks of accidents) and on society (increases health care costs and decreases job performance).

This study is designed to evaluate the efficacy and safety of a daily single oral dose of weight appropriate tasimelteon and matching placebo in male and female pediatric participants with insomnia disorder.

View Additional Information
View Clinical Trial Attachment
Sign Up NowExpired - View Other Trials
ENDED

Other Enrolling Clinical Trials

View All Enrolling Trials
Systemic Lupus Erythmatosus

This study is to demonstrate efficacy of litifilmab compared with placebo in participants with active SLE, who are receiving background lupus standard of care therapy in reducing disease activity.

View Trial
Tourette's Disorder

Efficacy and safety of gemlapodect in adults and adolescents with Tourette Syndrome.

View Trial
Pediatric Patients with Insomnia Disorder

To evaluate the efficacy of tasimelteon administered daily compared to placebo on Sleep Latency in pediatric and adolescent patients between the ages of 2-17.

View Trial
Sjögren Syndrome - RESOLVE

The purpose of the study is to evaluate the impact of RSLV-132 on dryness, tiredness/fatigue and pain in female participants with primary Sjögren's syndrome (pSS) with moderate to severe symptom burden and to assess its safety and tolerability.

View Trial
Asthma Clinical Trial - FLASH

The purpose of this study to Assess Efficacy and Safety of Multiple Dose Levels of AZD5718 Given Orally Once Daily for Twelve Weeks in Adults with Moderate-to-Severe Uncontrolled Asthma

View Trial
Adults with Moderate-to-Severe Plaque Psoriasis and Obesity

This study to see if weight loss improves plaque psoriasis

View Trial

Sign-Up, Make an Appointment, or Receive More Information

Thank you for your interest in our clinical research trials. Please enter your contact information below and someone will reach out to you shortly to see if you qualify. You can also call us at 1-800-785-3150 or email participate@onsiteclinical.com

By submitting this form, you are consenting to receive marketing emails from: OnSite Clinical Solutions, LLC, 11220 Elm Lane Suite 200 Charlotte, NC 28277, and will be able to revoke your consent to receive emails at any time.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.